Stocks
Funds
Screener
Sectors
Watchlists

Latest Crestline Management, LP Stock Portfolio

Crestline Management, LP Performance:
2025 Q4: 11.76%YTD: -12.32%2024: 5.88%

Performance for 2025 Q4 is 11.76%, and YTD is -12.32%, and 2024 is 5.88%.

About Crestline Management, LP and 13F Hedge Fund Stock Holdings

Crestline Management, LP is a hedge fund based in Fort Worth, TX. On 2026-02-17, the fund reported it's updated stock portfolio. In the 13F Holdings report, Crestline Management, LP reported an equity portfolio of $53.3 Millions as of 31 Dec, 2025.

The top stock holdings of Crestline Management, LP are DNLI, SANA, EGHT. The fund has invested 87% of it's portfolio in DENALI THERAPEUTICS INC and 9.3% of portfolio in SANA BIOTECHNOLOGY INC.

They significantly reduced their stock positions in SANA BIOTECHNOLOGY INC (SANA) and DENALI THERAPEUTICS INC (DNLI).

Crestline Management, LP Annual Return Estimates Vs S&P 500

Our best estimate is that Crestline Management, LP made a return of 11.76% in the last quarter. In trailing 12 months, it's portfolio return was -12.32%.
  • Performance
  • S&P 500

New Buys

No new stocks were added by Crestline Management, LP

Additions

No additions were made to existing positions by Crestline Management, LP

Reductions

Ticker% Reduced
sana biotechnology inc-32.95
denali therapeutics inc-17.59

Crestline Management, LP reduced stake in above stock

Sold off

None of the stocks were completely sold off by Crestline Management, LP

Sector Distribution

Crestline Management, LP has about 96.3% of it's holdings in Healthcare sector.

Sector%
Healthcare96.3
Technology3.7

Market Cap. Distribution

Crestline Management, LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

Category%
MID-CAP87
SMALL-CAP13

Stocks belong to which Index?

About 100% of the stocks held by Crestline Management, LP either belong to S&P 500 or RUSSELL 2000 index.

Index%
RUSSELL 2000100
Top 5 Winners (%)%
DNLI
denali therapeutics inc
12.5 %
SANA
sana biotechnology inc
12.2 %
Top 5 Winners ($)$
DNLI
denali therapeutics inc
6.2 M
SANA
sana biotechnology inc
0.8 M
Top 5 Losers (%)%
EGHT
8x8 inc new
-7.1 %
Top 5 Losers ($)$
EGHT
8x8 inc new
-0.1 M

Crestline Management, LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Crestline Management, LP

Crestline Management, LP has 3 stocks in it's portfolio. EGHT proved to be the most loss making stock for the portfolio. DNLI was the most profitable stock for Crestline Management, LP last quarter.

Last Reported on: 17 Feb, 2026
TickerNamesorted ascending% PortfolioShares Held$ ValueType% ChangeOptions